BOARD OF DIRECTORS

 

The Radix BioSolutions management team has experienced scientists and successful business talent. They are backed by a dedicated group of individuals, principally scientists by training, who are focused on applying immunoassay technology to enhance the research capabilities of Radix BioSolutions customers.

scott.jpg

Scott Edelman-CEO

Scott Edelman Mr. Scott Edelman has been affiliated with Radix since the spring of 2011, engaged as a part-time, consultant CEO. Scott is also the CEO of AdiCyte Inc., an adipose tissue and stem cell bank in Tucson, Arizona that he founded in late 2011 with Dr. David Harris and Mr. Steve Grant, two individuals that helped create and establish cord blood banking in the United States. Previous to these engagements, Scott provided strategic start-up and early stage consulting services to the Biodesign Institute at Arizona State University and to Hurel Corporation in the area of 3D cell culture models.

From 2003 through the summer of 2008, Scott was CEO, President, and Member of the Board of CellzDirect, a hepatic cell product and contract research organization that he grew profitably from zero to $19M in revenues in 5 years with angel and venture capital support. CellzDirect was sold to Life Technologies for $60M in 2008.

Scott is an active angel investor in numerous early stage life sciences companies, has a B.Sc. from the Pennsylvania State University, and resides in Tucson, Arizona.

 
kerry.jpg

Kerry Oliver, Ph.D.-President, CSO

Dr. Kerry Oliver has over thirty years of academic, government, industry experience in assay development. This work has spanned a broad range of disciplines including immunology and signal transduction biochemistry, diagnostic device development, and CRO services supporting various stages of therapeutic development. Following his Ph.D. in immunology from The University of Texas Southwestern Medical Center at Dallas, under the direction of Dr. Ellen Vitetta, Kerry received his postdoctoral training examining signal transduction pharmacology at the National Institutes of Health. Subsequently, Kerry spent three years in drug discovery.

In 1997, Kerry joined the R&D department at Luminex during its initial development of the xMAP® diagnostic platform. His initial responsibility at Luminex was to lead a team of assay development scientists to showcase the capabilities of the platform to early adopters of xMAP technology. In addition, he served as a liaison with key customers and strategic partners to expedite their adoption and commercialization of the platform.

In late 2001, Kerry founded Radix BioSolutions to satisfy unmet customer needs with custom molecular and immunoassay development, validation, and manufacturing. Radix products are used for customer’s in-house research, clinical trials, and environmental threat assessment and testing.

 

jack.jpg

Dr. John R. Kettman, Ph.D.

Dr. John R. Kettman received his undergraduate degree in biochemistry at the University of California, Berkeley and completed his Ph.D. at Oregon State University under the advisory of T. E. King. He completed his postdoctoral work in immunochemistry with E. Benjamini and immunobiology with R. W. Dutton. He was a member of the Basel Institute for Immunology from 1972-1973 and spent twenty eight years as on the faculty of the Microbiology Department at The University of Texas Southwestern Medical Center at Dallas. He currently serves as a Professor Emeritus in the Department of Immunology at The University of Texas Southwestern Medical School at Dallas. He was a co-founder of Luminex® Corporation and former Member of Board of Directors and is a partner and Member of the Board of Directors of Radix BioSolutions. He is author or co-author of over one hundred publications in reviewed scientific journals. 

 

R. Jerrold Fulton, Ph.D.

Dr. R. Jerrold Fulton received his B.A. in biology at The University of Texas at Austin in 1975 and went on to earn his Ph.D. in immunology at The University of Texas Southwestern Medical Center at Dallas in 1980 under the advisor Dr. David Hart. His postdoctoral work in immunochemistry and molecular biology was completed at Washington University in St. Louis, Missouri in the laboratories of Dr. Joseph Davies and Dr. Henry Huang. He served five years on the faculty of the Department of Microbiology at The University of Texas Southwestern Medical Center at Dallas. He was a co-founder of Luminex Corporation, Member of the Board of Directors, and Vice President for Research. He is a co-founder, partner, and Member of the Board of Directors of Radix BioSolutions and has written a number of scientific publications.